March 17, 2026
A strategic financial analysis of iPSC-based manufacturing vs. autologous models Author: ...
March 13, 2026
A co-development case from Cellistic & Quell Therapeutics Author: Cécile Augereau, PhD – ...
December 12, 2025
Abstract As cell therapies move from research toward clinical use, the shift from exploratory ...
December 11, 2025
Cellistic participates in this year’s ISSCR PSC-Derived Symposium, a gathering for innovators ...
November 3, 2025
Allogeneic iPSC-derived therapies hold immense promise, offering scalable, off-the-shelf ...
April 16, 2025
Natural Killer (NK) cell treatments are not readily accessible to patients due to persistent ...
.png)